Hims & Hers Health (HIMS) Research & Development (2021 - 2026)

Hims & Hers Health (HIMS) has 6 years of Research & Development data on file, last reported at $46.9 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 56.9% year-over-year to $46.9 million; the trailing twelve-month figure through Mar 2026 stood at $166.3 million (up 78.06% YoY), and the FY2025 full-year result was $149.3 million, up 89.42% from the prior year.
• Research & Development rose to $46.9 million in Q1 2026, from $41.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $46.9 million in Q1 2026 to a low of $6.1 million in Q1 2022.
• A 5-year average of $20.7 million and a median of $15.3 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development grew 27.8% in 2022 and soared 102.89% in 2025, its largest moves.
• Tracing HIMS's Research & Development over 5 years: stood at $8.3 million in 2022, then soared by 61.29% to $13.4 million in 2023, then jumped by 77.17% to $23.7 million in 2024, then jumped by 72.48% to $41.0 million in 2025, then gained by 14.58% to $46.9 million in 2026.
• Business Quant data shows HIMS's Research & Development at $46.9 million in Q1 2026, $41.0 million in Q4 2025, and $40.6 million in Q3 2025.